HCM Q1 2024 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q1 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$153M-42.6% YoY

Gross Profit

$63M41.1% margin

Operating Income

-$14M-9.0% margin

Net Income

$13M8.4% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

+0.2%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$25M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$509M

Stockholders' Equity

$740M

Cash & Equivalents

$204M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$153M	$266M	-42.6%
Gross Profit	$63M	$162M	-61.3%
Operating Income	-$14M	$56M	-124.6%
Net Income	$13M	$84M	-84.7%